The Lancet Group
+2
2352-3018
Monthly
16.1
2014
4401425462736
United Kingdom
English
YES
Google Scholar
lancet-ads@elsevier.com
The Lancet HIV is dedicated to publishing original research, evidence-based reviews, and insightful features that advocate for change in or illuminates HIV clinical practice. Delivering a holistic view of the pandemic, we publish content that unifies clinical, epidemiological, and operational disciplines across a single vision of health for those living with HIV. We cover innovative treatments and the biological research underpinning such developments, novel methods of service delivery, and new ways of confronting HIV/AIDS worldwide.The Lancet journals are both a destination for publication and a platform to advance the global impact of research. The Lancet Group cares that your work is highly visible to a global network of researchers, clinicians, industry professionals, policy makers, media outlets, patients, and the wider public, and we work with you and your affiliated institutions to maximise the impact of your research on the world.
Background As set out in Sustainable Development Goal 3.3, the target date for ending the HIV epidemic as a public health threat is 2030. Therefore, there is a crucial need to evaluate curr...
Background The sustainable development goals (SDGs) aim to end HIV/AIDS as a public health threat by 2030. Understanding the current state of the HIV epidemic and its change over time is es...
OJSCloud offers a complete, free setup to get you publishing.
Start Your Free Journal!